News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Precision BioSciences, Inc.
< Previous
1
2
3
4
Next >
Precision BioSciences Announces Preclinical Data Showcasing Premier In Vivo Gene Editing Capabilities at American Society of Gene & Cell Therapy Annual Meeting
May 16, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 12, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Reports First Quarter 2022 Financial Results and Provides Business Update
May 09, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Present Preclinical In Vivo Gene Editing Research at Upcoming American Society of Gene & Cell Therapy 25th Annual Meeting
May 02, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Report First Quarter 2022 Financial Results on May 9, 2022
May 02, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update
March 15, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Present at the 40th Annual J.P. Morgan Health Care Conference
January 04, 2022
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Completes Spin-Out of Elo Life Systems
December 21, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Reports Clinical Program Updates for Its Allogeneic CAR T Pipeline
December 11, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Host Virtual Webcast and Conference Call to Review Interim Phase 1/2a PBCAR0191 CAR T Data and Provide CAR T Program Updates on Saturday, December 11, 2021
December 06, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Present Preclinical Gene Editing Data on its ARCUS-Based Chronic Hepatitis B Program at the HEP DART 2021 Conference
December 03, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Reports Third Quarter 2021 Financial Results and Provides Business Update
November 10, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36th Annual Meeting
November 09, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Appoints Sam Wadsworth, Ph.D. and Shari Lisa Piré, J.D. to Board of Directors
November 08, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Announces Two Oral Presentations Highlighting Updated Interim Data from Lead PBCAR0191 CAR T Immunotherapy for Relapsed and Refractory B-cell Malignancies at the 63rd Annual Meeting of the American Society of Hematology
November 04, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Report Third Quarter 2021 Financial Results on November 10, 2021 and Participate in the Stifel 2021 Virtual Healthcare Conference on November 16, 2021
November 03, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Present at the Jefferies Virtual Gene Therapy/Editing Summit on Thursday, October 27, 2021
October 21, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Announces Grant of Inducement Award for Newly Appointed Chief Executive Officer Pursuant to Nasdaq Listing Rule 5635(c)(4)
September 27, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Appoints Michael Amoroso Chief Executive Officer
September 27, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 10, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Outlines Clinical Development Strategy for In Vivo Gene Editing Pipeline
September 09, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences and iECURE Announce License and Collaboration Agreement to Develop ARCUS-Based Gene Editing Therapies
September 09, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment
September 02, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
TLSA
Precision BioSciences to Host In Vivo Gene Editing R&D Event on September 9, 2021
August 25, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Reports Second Quarter 2021 Financial Results and Provides Business Update
August 12, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences to Report Second Quarter 2021 Financial Results on August 12, 2021
August 05, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Doses First Patient in Phase 1 Allogeneic CAR T Clinical Trial of PBCAR19B Immune Evading Stealth Cell for Relapsed/Refractory Non-Hodgkin Lymphoma
July 01, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma
June 28, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
SWTX
Precision BioSciences Reports Progress on Two Strategies Designed to Optimize Durability of Allogeneic CAR T Therapy in R/R Non-Hodgkin Lymphoma
June 04, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo
June 01, 2021
From
Precision BioSciences, Inc.
Via
Business Wire
Tickers
DTIL
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.